Evaluating the appropriateness of dosing adjustments in the coadministration of maraviroc and CYP3A inhibitors: A literature review

The use of an extended (once-daily) dosing interval is not supported by current data and such an adjustment may lead to poor viral suppression and potential treatment failure.